Table 1.
Baseline characteristics of study population (n = 159)
| Variables | Values |
| Demographic variables | |
| Age, yr | 56.0 ± 10.6 |
| Male gender | 87 (54.7) |
| Body mass index, kg/m2 | 24.3 ± 3.1 |
| Diabetes mellitus | 19 (11.9) |
| Hypertension | 40 (25.2) |
| Daily alcohol intake, mg | 15.4 ± 30.5 |
| Laboratory variables | |
| Aspartate aminotransferase, IU/L | 23.3 ± 8.5 |
| Alanine aminotransferase, IU/L | 23.1 ± 12.2 |
| Platelet count, 109/L | 235.5 ± 57.9 |
| Fasting plasma glucose, mg/dL | 100.5 ± 24.5 |
| HOMA-IR | 1.84 ± 1.35 |
| HbA1c, % | 6.0 ± 0.7 |
| Imaging variables | |
| Severe fatty liver on sonography | 30 (18.9) |
| Carotid sonography | |
| Intimal media thickness, mm | 0.75 ± 0.57 |
| Presence of carotid plaque | 34 (21.4) |
| Calcified carotid plaque, n | 0.48 ± 1.13 |
| Computed tomography | |
| Visceral fat area, cm2 | 112.4 ± 54.8 |
| Transient elastography | |
| Controlled attenuation parameter, dB/m | 248.3 ± 44.4 |
| Interquartile rangeCAP, dB/m | 35.91 ± 13.56 |
| Interquartile range/medianCAP | 0.16 ± 0.06 |
| Liver stiffness value, kPa | 4.7 ± 2.2 |
| Interquartile rangeLS, kPa | 0.52 ± 0.21 |
| Interquartile range/medianLS | 0.13 ± 0.06 |
Values are expressed as the mean ± SD (range) or n (%). HOMA-IR: Homeostasis model assessment of insulin resistance; HbA1c: Glycated hemoglobin; CAP: Controlled attenuation parameter; LS: Liver stiffness.